$AZEK
AZEK Co Inc.

2020 Q4 Form 10-Q Financial Statement

#000119312521041464 Filed on February 12, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q4
Revenue $212.3M $263.9M $166.0M
YoY Change 27.85% 22.45% 20.82%
Cost Of Revenue $139.3M $173.7M $114.8M
YoY Change 21.39% 18.89% 18.91%
Gross Profit $72.98M $90.26M $51.29M
YoY Change 42.28% 29.92% 25.39%
Gross Profit Margin 34.38% 34.2% 30.89%
Selling, General & Admin $53.45M $149.8M $43.47M
YoY Change 22.95% 202.63% 2.05%
% of Gross Profit 73.24% 165.96% 84.76%
Research & Development $1.800M $2.000M $2.100M
YoY Change -14.29% 23.53%
% of Gross Profit 2.47% 2.22% 4.09%
Depreciation & Amortization $24.28M $24.56M $24.14M
YoY Change 0.57% 1.11% 7.48%
% of Gross Profit 33.27% 27.21% 47.07%
Operating Expenses $55.25M $151.8M $45.57M
YoY Change 21.23% 206.67% 2.87%
Operating Profit $19.53M -$61.54M $5.913M
YoY Change 230.29% -408.05% -274.22%
Interest Expense $6.026M -$6.300M $19.76M
YoY Change -69.5% -68.5% -196.39%
% of Operating Profit 30.86% 334.16%
Other Income/Expense, Net $6.026M $19.76M
YoY Change -69.5%
Pretax Income $13.50M -$68.40M -$13.85M
YoY Change -197.53% -44.84%
Income Tax $3.356M -$4.100M -$4.000M
% Of Pretax Income 24.85%
Net Earnings $10.15M -$64.36M -$9.846M
YoY Change -203.07% 6895.54% -48.91%
Net Earnings / Revenue 4.78% -24.39% -5.93%
Basic Earnings Per Share $0.07 -$0.43 -$0.09
Diluted Earnings Per Share $0.07 -$0.43 -$0.09
COMMON SHARES
Basic Shares Outstanding 153.2M 108.2M
Diluted Shares Outstanding 156.0M 108.2M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $210.0M $215.0M $22.50M
YoY Change 833.33%
Cash & Equivalents $210.0M $215.0M $22.47M
Short-Term Investments
Other Short-Term Assets $161.0K $360.0K $19.90M
YoY Change -99.19% -96.6%
Inventory $166.2M $130.1M $139.3M
Prepaid Expenses $11.41M $8.367M
Receivables $41.23M $70.89M $55.50M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $429.0M $424.7M $237.3M
YoY Change 80.78% 46.15%
LONG-TERM ASSETS
Property, Plant & Equipment $279.2M $261.8M $216.2M
YoY Change 29.13% 25.43%
Goodwill $951.4M $951.4M
YoY Change 0.75%
Intangibles $279.7M $292.4M
YoY Change -14.61%
Long-Term Investments
YoY Change
Other Assets $1.608M $1.623M $2.900M
YoY Change -44.55% -28.28%
Total Long-Term Assets $1.512B $1.507B $1.492B
YoY Change 1.33% 0.63%
TOTAL ASSETS
Total Short-Term Assets $429.0M $424.7M $237.3M
Total Long-Term Assets $1.512B $1.507B $1.492B
Total Assets $1.941B $1.932B $1.729B
YoY Change 12.24% 8.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $38.18M $42.06M $20.80M
YoY Change 83.55% -11.42%
Accrued Expenses $71.20M $75.40M $62.90M
YoY Change 13.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $9.200M
YoY Change
Total Short-Term Liabilities $114.4M $124.0M $96.30M
YoY Change 18.83% -11.4%
LONG-TERM LIABILITIES
Long-Term Debt $463.3M $463.0M $1.113B
YoY Change -58.39% -58.04%
Other Long-Term Liabilities $9.009M $19.69M $9.700M
YoY Change -7.12% 101.99%
Total Long-Term Liabilities $472.3M $482.7M $1.123B
YoY Change -57.95% -56.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $114.4M $124.0M $96.30M
Total Long-Term Liabilities $472.3M $482.7M $1.123B
Total Liabilities $621.8M $628.0M $1.249B
YoY Change -50.23% -51.63%
SHAREHOLDERS EQUITY
Retained Earnings -$273.3M -$283.5M
YoY Change 74.36%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.321B $1.304B $480.0M
YoY Change
Total Liabilities & Shareholders Equity $1.941B $1.932B $1.729B
YoY Change 12.24% 8.03%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q4
OPERATING ACTIVITIES
Net Income $10.15M -$64.36M -$9.846M
YoY Change -203.07% 6895.54% -48.91%
Depreciation, Depletion And Amortization $24.28M $24.56M $24.14M
YoY Change 0.57% 1.11% 7.48%
Cash From Operating Activities $20.30M $87.07M -$56.36M
YoY Change -136.01% 16.7% 11.74%
INVESTING ACTIVITIES
Capital Expenditures $27.02M -$40.82M $19.13M
YoY Change 41.24% 146.35% -247.84%
Acquisitions
YoY Change
Other Investing Activities $20.00K $30.00K $110.0K
YoY Change -81.82% 50.0%
Cash From Investing Activities -$27.00M -$40.79M -$19.02M
YoY Change 41.99% 146.47% 46.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.728M -46.38M -8.100M
YoY Change -121.33% 1488.36% 163.84%
NET CHANGE
Cash From Operating Activities 20.30M 87.07M -56.36M
Cash From Investing Activities -27.00M -40.79M -19.02M
Cash From Financing Activities 1.728M -46.38M -8.100M
Net Change In Cash -4.978M -100.0K -83.48M
YoY Change -94.04% -100.18% 25.63%
FREE CASH FLOW
Cash From Operating Activities $20.30M $87.07M -$56.36M
Capital Expenditures $27.02M -$40.82M $19.13M
Free Cash Flow -$6.723M $127.9M -$75.49M
YoY Change -91.09% 40.26% 101.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
210034000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
215012000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41234000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
70886000
CY2020Q4 us-gaap Inventory Net
InventoryNet
166151000
CY2020Q3 us-gaap Inventory Net
InventoryNet
130070000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11412000
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8367000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
161000
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
360000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
428992000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
424695000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
279183000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
261774000
CY2020Q4 us-gaap Goodwill
Goodwill
951390000
CY2020Q3 us-gaap Goodwill
Goodwill
951390000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
279731000
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
292374000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1608000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1623000
CY2020Q4 us-gaap Assets
Assets
1940904000
CY2020Q3 us-gaap Assets
Assets
1931856000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
37544000
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
33850000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
19604000
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
19935000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
109003000
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
76285000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
500963000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
472175000
CY2020Q4 azek Build To Suit Right Of Use Asset
BuildToSuitRightOfUseAsset
9200000
CY2020Q3 azek Build To Suit Liability
BuildToSuitLiability
7900000
CY2020Q4 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
500000
CY2019Q4 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
200000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
38179000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
42059000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
CY2020Q4 azek Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
39408000
CY2020Q3 azek Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
50516000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
114430000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
124040000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
24168000
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
21260000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10886000
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10910000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
463308000
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
462982000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9009000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8776000
CY2020Q4 us-gaap Liabilities
Liabilities
621801000
CY2020Q3 us-gaap Liabilities
Liabilities
627968000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1592240000
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1587208000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-273292000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-283475000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1319103000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1303888000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1940904000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1931856000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1089000
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
1103000
CY2020Q4 us-gaap Revenues
Revenues
212278000
CY2019Q4 us-gaap Revenues
Revenues
166043000
CY2020Q4 us-gaap Cost Of Revenue
CostOfRevenue
139302000
CY2019Q4 us-gaap Cost Of Revenue
CostOfRevenue
114752000
CY2020Q4 us-gaap Gross Profit
GrossProfit
72976000
CY2019Q4 us-gaap Gross Profit
GrossProfit
51291000
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53029000
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
43473000
CY2020Q4 us-gaap Other General Expense
OtherGeneralExpense
0
CY2019Q4 us-gaap Other General Expense
OtherGeneralExpense
1978000
CY2020Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-212000
CY2019Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
73000
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
19735000
CY2020Q3 azek Accrued Rebates Current
AccruedRebatesCurrent
32679000
CY2019Q3 azek Accrued Rebates Current
AccruedRebatesCurrent
24858000
CY2020Q4 azek Rebate Expense
RebateExpense
13673000
CY2019Q4 azek Rebate Expense
RebateExpense
10314000
CY2020Q4 azek Payments For Rebate
PaymentsForRebate
-7533000
CY2019Q4 azek Payments For Rebate
PaymentsForRebate
-8023000
CY2020Q4 azek Accrued Rebates Current
AccruedRebatesCurrent
38819000
CY2019Q4 azek Accrued Rebates Current
AccruedRebatesCurrent
27149000
CY2019Q4 azek Accrued Rebates
AccruedRebates
24900000
CY2020Q4 azek Contra Trade Receivable
ContraTradeReceivable
3100000
CY2019Q4 azek Contra Trade Receivable
ContraTradeReceivable
2200000
CY2020Q4 azek Property Plant And Equipment Excluding Construction In Progress Gross
PropertyPlantAndEquipmentExcludingConstructionInProgressGross
439215000
CY2020Q3 azek Property Plant And Equipment Excluding Construction In Progress Gross
PropertyPlantAndEquipmentExcludingConstructionInProgressGross
417763000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
221780000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
210401000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
5913000
CY2020Q4 us-gaap Interest Expense
InterestExpense
6196000
CY2019Q4 us-gaap Interest Expense
InterestExpense
19759000
CY2020Q4 us-gaap Other Expenses
OtherExpenses
6196000
CY2019Q4 us-gaap Other Expenses
OtherExpenses
19759000
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13539000
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13846000
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3356000
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
10183000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-9846000
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10183000
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9846000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
490023000
CY2019Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
684000
CY2020Q4 us-gaap Depreciation
Depreciation
11627000
CY2019Q4 us-gaap Depreciation
Depreciation
10283000
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12643000
CY2019Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13858000
CY2020Q4 azek Noncashinterest Expense
NoncashinterestExpense
467000
CY2019Q4 azek Noncashinterest Expense
NoncashinterestExpense
997000
CY2020Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2908000
CY2019Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2653000
CY2020Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29652000
CY2019Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2923000
CY2020Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
36081000
CY2019Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23926000
CY2020Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2846000
CY2019Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-296000
CY2020Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5097000
CY2019Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-25042000
CY2020Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6537000
CY2019Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-17460000
CY2020Q4 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-106000
CY2019Q4 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
928000
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20115000
CY2019Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-56361000
CY2020Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27021000
CY2019Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19131000
CY2020Q4 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17000
CY2019Q4 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
113000
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27004000
CY2019Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19018000
CY2019Q4 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
2076000
CY2020Q4 azek Proceeds Repayments Of Finance Lease Obligations
ProceedsRepaymentsOfFinanceLeaseObligations
-243000
CY2019Q4 azek Proceeds Repayments Of Finance Lease Obligations
ProceedsRepaymentsOfFinanceLeaseObligations
-193000
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1911000
CY2019Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8100000
CY2020Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4978000
CY2019Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-83479000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105947000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22468000
CY2020Q4 us-gaap Interest Paid Net
InterestPaidNet
5847000
CY2019Q4 us-gaap Interest Paid Net
InterestPaidNet
25045000
CY2020Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-56000
CY2019Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6000
CY2020Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4035000
CY2019Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2007000
CY2020Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
819700000
CY2020Q2 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
50600000
CY2020Q2 azek Accrued Liabilities For Estimated Offering Expenses
AccruedLiabilitiesForEstimatedOfferingExpenses
9200000
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1800000
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2100000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
670886000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
391155000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
279731000
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
670886000
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
378512000
CY2019Q4 us-gaap Stockholders Equity Other
StockholdersEquityOther
-2201000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
479996000
CY2020Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
32200000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
292374000
CY2020Q4 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P12Y9M18D
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18555000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26554000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1652000
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4249000
CY2020Q4 azek Accrued Freight Payable Current
AccruedFreightPayableCurrent
3805000
CY2020Q3 azek Accrued Freight Payable Current
AccruedFreightPayableCurrent
5530000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2681000
CY2020Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2921000
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2859000
CY2020Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3343000
CY2020Q4 azek Accrued Construction In Progress Liability Current
AccruedConstructionInProgressLiabilityCurrent
2054000
CY2020Q3 azek Accrued Construction In Progress Liability Current
AccruedConstructionInProgressLiabilityCurrent
1303000
CY2020Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
1047000
CY2020Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
969000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3979000
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3983000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1332000
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
904000
CY2020Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-6000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-512000
CY2020 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
119000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1338000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
467182000
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
467147000
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
CY2020Q4 us-gaap Interest Expense Other
InterestExpenseOther
373000
CY2019Q4 us-gaap Interest Expense Other
InterestExpenseOther
385000
CY2020Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
35000
CY2019Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
60000
CY2020Q4 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
486000
CY2019Q4 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
218000
CY2020Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
10913000
CY2019Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11133000
CY2020Q4 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
723000
CY2019Q4 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1372000
CY2020Q4 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
608000
CY2019Q4 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
950000
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11044000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11588000
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24270000
CY2019Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24141000
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2980000
CY2019Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
685000
CY2020Q4 azek Adjusted Earnings Before Interest Tax Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization
62092000
CY2019Q4 azek Adjusted Earnings Before Interest Tax Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization
41938000
CY2020Q4 azek Unallocated Net Expenses
UnallocatedNetExpenses
13640000
CY2019Q4 azek Unallocated Net Expenses
UnallocatedNetExpenses
8132000
CY2019Q4 us-gaap Restructuring Charges
RestructuringCharges
163000
CY2019Q4 azek Business Combination Total Costs
BusinessCombinationTotalCosts
565000
CY2020Q4 us-gaap Interest Expense
InterestExpense
6196000
CY2019Q4 us-gaap Interest Expense
InterestExpense
19759000
CY2020Q4 azek Other Costs Expense
OtherCostsExpense
1467000
CY2019Q4 azek Other Costs Expense
OtherCostsExpense
361000
CY2020Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
500000
CY2019Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
33600000
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10183000
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9846000
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.248
CY2019Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.289
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
9200000
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.084
CY2020Q4 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1278000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
2177000
CY2020Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
1597000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2763000
CY2020Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
1206000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2563000
CY2020Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
828000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2159000
CY2020Q4 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
616000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1719000
CY2020Q4 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
2191000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
3397000
CY2020Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
7716000
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
14778000
CY2020Q4 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
3687000
CY2020Q4 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
4029000
CY2020Q4 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
607000
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
787000
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
806000
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
826000
CY2020Q4 azek Finance Lease Future Minimum Payments Due
FinanceLeaseFutureMinimumPaymentsDue
7695000
CY2020Q4 azek Finance Lease Liability Payments Due In Five Years
FinanceLeaseLiabilityPaymentsDueInFiveYears
846000
CY2019Q4 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000
CY2020Q4 azek Accrued Rebates
AccruedRebates
35754000
CY2020Q3 azek Accrued Rebates
AccruedRebates
30362000
CY2020Q4 azek Property Plant And Equipment Acquired Under Finance Leases
PropertyPlantAndEquipmentAcquiredUnderFinanceLeases
334000
CY2019Q4 azek Property Plant And Equipment Acquired Under Finance Leases
PropertyPlantAndEquipmentAcquiredUnderFinanceLeases
446000
CY2020Q4 azek Non Cash Compensation Expense
NonCashCompensationExpense
2878000
CY2019Q4 azek Non Cash Compensation Expense
NonCashCompensationExpense
1056000
CY2020 azek Allowance For Doubtful Accounts Receivable Business Combination Increase
AllowanceForDoubtfulAccountsReceivableBusinessCombinationIncrease
35000
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3874000
CY2020Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4165000
CY2020Q4 azek Standard Product Warranty Accretion Purchase Accounting Valuation
StandardProductWarrantyAccretionPurchaseAccountingValuation
16000
CY2019Q4 azek Standard Product Warranty Accretion Purchase Accounting Valuation
StandardProductWarrantyAccretionPurchaseAccountingValuation
33000
CY2020Q4 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
3823000
CY2020Q4 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2020Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001782754
CY2020Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1017663
CY2020Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q4 dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q4 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020Q4 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
1330 W Fulton Street, Suite 350
CY2020Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
CY2020Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2020Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60607
CY2020Q4 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.001 per share
CY2020Q4 dei Trading Symbol
TradingSymbol
AZEK
CY2020Q4 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 azek Initial Public Offering And Secondary Offering Costs
InitialPublicOfferingAndSecondaryOfferingCosts
-1978000
CY2020Q4 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Significant estimates include revenue recognition, reserves for excess inventory, inventory obsolescence, product warranties, customer rebates, stock-based compensation, litigation, income taxes, contingent consideration, goodwill and intangible asset valuation and accounting for long-lived assets. Management&#8217;s estimates and assumptions are evaluated on an ongoing basis and are based on historical experience, current conditions and available information. Actual results may differ from estimated amounts. Estimates are revised as additional information becomes available. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2364000
CY2020Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
210000
CY2019Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3630000
CY2019Q4 azek Payment Of Capital Contribution
PaymentOfCapitalContribution
2201000
CY2019Q4 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
600000
CY2020Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2020Q4 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The Class A common stock and Class B common stock provide identical economic rights, but holders of Class B common stock have limited voting rights, specifically that such holders have no right to vote, solely with respect to their shares of Class B common stock, with respect to the election, replacement or removal of directors.
CY2020Q4 us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
Class A common stock and Class B common stock are not entitled to preemptive rights. Holders of Class B common stock may convert their shares of Class B common stock into shares of Class A common stock on a one-for-one basis, in whole or in part, at any time and from time to time at their option.
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153226378
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108162741
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156018731
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108162741
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
467700000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0056
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3500
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2020Q4 us-gaap Standard Product Warranty Description
StandardProductWarrantyDescription
The Company provides product assurance warranties of various lengths ranging from 5 years to lifetime for limited coverage for a variety of material and workmanship defects based on standard terms and conditions between the Company and its customers.
CY2020Q3 azek Build To Suit Right Of Use Asset
BuildToSuitRightOfUseAsset
9200000
CY2020Q4 azek Build To Suit Liability
BuildToSuitLiability
7900000
CY2020Q4 dei Document Type
DocumentType
10-Q
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
184851
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
23.00
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
173734
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
34.51
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
353897
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
28.70
CY2020Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
173
CY2020Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
2681000
CY2019Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
3001000
CY2020Q4 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
8363000
CY2019Q4 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
8587000
CY2020Q4 dei Entity File Number
EntityFileNumber
001-39322
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
4688
CY2020Q4 azek Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Forfeited Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageForfeitedDateFairValue
23.00
CY2020Q4 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2878000
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2364000
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-210000
CY2020Q4 us-gaap Legal Fees
LegalFees
500000
CY2020Q4 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
600000
CY2020Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions
FutureMinimumSubleaseRentalsSaleLeasebackTransactions
1100000
CY2020Q4 azek Accrued Manufacturing Cost Payable Current
AccruedManufacturingCostPayableCurrent
2776000
CY2020Q3 azek Accrued Manufacturing Cost Payable Current
AccruedManufacturingCostPayableCurrent
1664000
CY2020Q4 dei Entity Registrant Name
EntityRegistrantName
AZEK Co Inc.
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
39408000
CY2020Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
50516000

Files In Submission

Name View Source Status
R24.htm Edgar Link pending
0001193125-21-041464-index-headers.html Edgar Link pending
0001193125-21-041464-index.html Edgar Link pending
0001193125-21-041464.txt Edgar Link pending
0001193125-21-041464-xbrl.zip Edgar Link pending
azek-20201231.xml Edgar Link completed
azek-20201231.xsd Edgar Link pending
azek-20201231_cal.xml Edgar Link unprocessable
azek-20201231_def.xml Edgar Link unprocessable
azek-20201231_lab.xml Edgar Link unprocessable
azek-20201231_pre.xml Edgar Link unprocessable
d25564d10q.htm Edgar Link pending
d25564dex311.htm Edgar Link pending
d25564dex312.htm Edgar Link pending
d25564dex321.htm Edgar Link pending
d25564dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending